New Promising Alzheimer's Drug May Prevent Tau Build-Up, Study Finds

In both the lab and fruit fly studies, RI-AG03 was found to prevent the buildup of tau proteins, which play a key role in Alzheimer's disease and other neurodegenerative disorders. (Credit: Image by Freepik)

Researchers have developed a new drug that holds promise in Alzheimer's treatment by blocking tau-build-up, acting at two regions of the protein, preventing it from sticking together.

The latest drug, RI-AG03, is a peptide inhibitor developed by a research team led by Lancaster University in collaboration with the University of Southampton, Nottingham Trent University, Tokyo Metropolitan Institute of Medical Science, and the University of Texas Southwestern Medical Center.